Ligand Pharmaceuticals

-$6.20 (-3.95%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

CEO
John L. Higgins
Employees
155
Headquarters
San Diego, California
Founded
1987

LGND Key Statistics

Market cap
2.52B
Price-Earnings ratio
39.38
Dividend yield
—
Average volume
113.62K
High today
$158.24
Low today
$149.60
Open price
$158.24
Volume
103.38K
52 Week high
$219.75
52 Week low
$84.97

LGND News

Simply Wall St15h

Is Ligand Pharmaceuticals A Risky Investment?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of de

LGND Earnings

$0.00
$0.54
$1.09
$1.63
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure